Cargando…
Histone deacetylases as targets for antitrypanosomal drugs
Parasitic protozoa comprise several species that are causative agents of important diseases. These diseases are distributed throughout the world and include leishmaniasis, Chagas disease and sleeping sickness, malaria and toxoplasmosis. Treatment is based on drugs that were developed many years ago,...
Autores principales: | Zuma, Aline A, de Souza, Wanderley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153458/ https://www.ncbi.nlm.nih.gov/pubmed/30271613 http://dx.doi.org/10.4155/fsoa-2018-0037 |
Ejemplares similares
-
Use of Nanocarriers Containing Antitrypanosomal Drugs for the Treatment of Chagas Disease
por: Paiva, Diogo de Freitas, et al.
Publicado: (2023) -
Histone Deacetylase Inhibitors as Anticancer Drugs
por: Eckschlager, Tomas, et al.
Publicado: (2017) -
Trypanothione Reductase: A Viable Chemotherapeutic Target for Antitrypanosomal and Antileishmanial Drug Design
por: Khan, M. Omar F.
Publicado: (2007) -
Targeting histone deacetylases for the treatment of disease
por: Lawless, M W, et al.
Publicado: (2009) -
Histone Deacetylase Enzymes as Potential Drug Targets in Cancer and Parasitic Diseases
por: Ouaissi, Mehdi, et al.
Publicado: (2006)